NCT05187403View on ClinicalTrials.gov

A Study of Laquinimod Eye-drops in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

January 19, 2023

Study Completion Date

January 19, 2023

Conditions

Eye Diseases

Interventions

DRUG

Laquinimod

Eye-drops

DRUG

Placebo

Eye-drops

Trial Locations (1)

Unknown

Clinical trial center at Medical University Vienna, Vienna

Sponsors

Lead Sponsor

Active Biotech AB

All Listed Sponsors

lead

Active Biotech AB

INDUSTRY

NCT05187403 - A Study of Laquinimod Eye-drops in Healthy Participants | Biotech Hunter | Biotech Hunter